Literature DB >> 19030000

Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia.

Eswari Vilayur1, Paul Trevillian, Mark Walsh.   

Abstract

BACKGROUND: A 42-year-old previously healthy man was referred to hospital with an 8-week history of fevers, night sweats, fatigue, and unintentional weight loss. There was no past history of medical illness or any medication use. Physical examination was unremarkable. On urinalysis, the patient had hematuria (grade 4+) and proteinuria (grade 4+). INVESTIGATIONS: Urine phase-contrast microscopy, full blood count, renal function tests, 24-h urine collection for protein, serum immune electrophoresis, renal biopsies, phase-contrast microscopy, serological tests for antinuclear antibodies, extractable nuclear antigens, antineutrophil cytoplasmic antibodies, hepatitis B, hepatitis C and HIV, cryoglobulin test, complement testing, flow cytometry of the peripheral blood, and bone marrow biopsy. DIAGNOSIS: Monoclonal gammopathy and a glomerulopathy, with microtubular deposits, associated with chronic lymphocytic leukemia. MANAGEMENT: Treatment with prednisone and cyclophosphamide did not improve proteinuria, although lymphocyte count returned to normal. The patient did not tolerate high-dose cyclophosphamide and was started on rituximab. His proteinuria completely resolved and there was complete disappearance of the microtubules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030000     DOI: 10.1038/ncpneph0989

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  7 in total

Review 1.  Immunotactoid glomerulopathy.

Authors:  Melvin M Schwartz; Stephen M Korbet; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

2.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Bela Ivanyi; Peter Degrell
Journal:  Nephrol Dial Transplant       Date:  2004-09       Impact factor: 5.992

3.  Lobular membranoproliferative glomerulonephritis with organized microtubular monoclonal immunoglobulin deposits associated with B cell small lymphocytic lymphoma.

Authors:  Kei Matsushita; Kiyotaka Nagahama; Yoshiaki Inayama; Katsumichi Fujimaki; Kouichi Tamura; Nobuhito Hirawa; Minoru Kihara; Yoshiyuki Toya; Machiko Yabana; Kensuke Joh; Satoshi Umemura
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

4.  Immuotactoid glomerulopathy (fibrillary glomerulonephritis).

Authors:  Stephen M Korbet; Melvin M Schwartz; Edmund J Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 8.237

5.  Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

Authors:  H R Galea; F Bridoux; J-C Aldigier; F Paraf; D Bordessoule; G Touchard; M Cogné
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

6.  Rituximab treatment of idiopathic membranous nephropathy.

Authors:  F C Fervenza; F G Cosio; S B Erickson; U Specks; A M Herzenberg; J J Dillon; N Leung; I M Cohen; D N Wochos; E Bergstralh; M Hladunewich; D C Cattran
Journal:  Kidney Int       Date:  2007-10-17       Impact factor: 10.612

7.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

  7 in total
  4 in total

Review 1.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

2.  Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.

Authors:  Zeenat Y Bhat; Xu Zeng; Jaideep Hingorani; Salman Khan; Madhumita Jena Mohanty
Journal:  Int Urol Nephrol       Date:  2011-11-19       Impact factor: 2.370

3.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Authors:  Sanjeev Sethi; Ladan Zand; Nelson Leung; Richard J H Smith; Dragan Jevremonic; Sandra S Herrmann; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

Review 4.  Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.

Authors:  Michael Rudnicki
Journal:  Biomed Res Int       Date:  2017-05-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.